| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 02/23/2005 | CN1583148A Preparation of oriental waterplantain pieces |
| 02/23/2005 | CN1583147A Preparation of oriental waterplantain pieces |
| 02/23/2005 | CN1583129A Health care medicinal composition for regulating blood fat and its preparation |
| 02/23/2005 | CN1583104A Chinese herbal medicine and its use |
| 02/23/2005 | CN1583087A Chinese health-care medicine for reducing blood sugar and preventing from diabete complication and its preparation |
| 02/23/2005 | CN1583068A Health care food for regulating blood sugar and immunologic function |
| 02/23/2005 | CN1583054A Detoxic defatting preparation and its preparation |
| 02/23/2005 | CN1583014A Composite Chinese medicine for non-insulin dependent diabete and its preparation |
| 02/23/2005 | CN1583008A Medicine defatting and face nourishing |
| 02/23/2005 | CN1582999A Composite preparation of defatting and shaping body by consuming fat and its preparing method |
| 02/23/2005 | CN1582985A Medicine for diabetes and its preparation |
| 02/23/2005 | CN1582984A Frozen dry powder injection of astrogalus root and its preparing method |
| 02/23/2005 | CN1582971A Blood fat reducing preparation and its preparing method and use |
| 02/23/2005 | CN1582963A Preparation of biochemical nutrients for ostrich |
| 02/23/2005 | CN1582959A Health care food for defatting |
| 02/23/2005 | CN1582957A Preparation of medicines from hippophae rhamnoides for reducing blood sugar and cholesterol |
| 02/23/2005 | CN1582950A Medicinal composition and its preparation and use |
| 02/23/2005 | CN1582947A Capsules of alpha-linolinic acid |
| 02/23/2005 | CN1582930A Use of Chinese medicinal Bamatin in treatment of diabetes II |
| 02/23/2005 | CN1582928A Medicinal composition and its use in treatment of diabetes |
| 02/23/2005 | CN1582922A Sustained releasing preparation of vilamin C and its preparing method |
| 02/23/2005 | CN1582919A Preparation of medicines for reducing blood sugar and triglyceride from hippophae rhamnoides flavone |
| 02/23/2005 | CN1582910A Calcium phenol sulfonate dispersive tablets and their preparation |
| 02/23/2005 | CN1582760A Nucleotide and amino acid nutrient products and their production |
| 02/23/2005 | CN1190549C Weight-lossing fabric and its preparing process |
| 02/23/2005 | CN1190434C Novel heterocyclic compounds and process for its preparation, and pharmaceutical compositions containing them and their use in treatment of diabetes and related diseases |
| 02/23/2005 | CN1190420C Non-peptide neomatal vascularization inhibitor |
| 02/23/2005 | CN1190394C Pineapplie leaf extract and its preparation method and application |
| 02/23/2005 | CN1190220C Hypoglycemic tea and preparing process thereof |
| 02/23/2005 | CN1190200C Compsns. comprising mixture of bioflavonols |
| 02/23/2005 | CN1190192C Capsule agent with grape-seed extracts as raw material |
| 02/22/2005 | US6858723 Amphiphile cyclodextrins, preparation and use thereof for solubilizing organized systems and incorporating hydrophobic molecules |
| 02/22/2005 | US6858651 2,3-oxidosqualene-lanosterol cyclase inhibitors |
| 02/22/2005 | US6858645 Prevention or the treatment of CNS disorders and related medical disturbances comprising effective amount of the salt according dissolving (R)-3-N,N-dicyclobutylamino-8-fluoro-3,4-dihydro-2H-1-benzopyran-5 -carboxamide in an appropriate |
| 02/22/2005 | US6858643 Crystalline forms of Fluvastatin sodium |
| 02/22/2005 | US6858642 For use in pharmaceutical, skin-protective and cosmetic formulations |
| 02/22/2005 | US6858629 Heteroaryloxy propanolamines, preparation method and pharmaceutical compositions containing same |
| 02/22/2005 | US6858628 Substituted cyclic amine metalloprotease inhibitors |
| 02/22/2005 | US6858627 For therapy of inflammatory, allergic, or proliferative conditions |
| 02/22/2005 | US6858624 Comprises 5,8,14-triazatetracyclo(10.3.1.0.0)-hexadeca-2(11),3,5,7,9-penaene groups; for reducing drug addiction, treating Alzheimer's/Parkinson's diseases, and other nervous system disorders |
| 02/22/2005 | US6858622 Cycloalkano-indole and -azaindole derivatives |
| 02/22/2005 | US6858619 Fused heterocyclic compounds |
| 02/22/2005 | US6858618 Use of rosuvastatin (zd-4522) in the treatment of heterozygous familial hypercholesterolemia |
| 02/22/2005 | US6858604 Cyclohepta[b][1,4]diazepino[6,7,1-hi]indoles and derivatives |
| 02/22/2005 | US6858603 Acetindine derivatives, their preparation and medicaments containing them |
| 02/22/2005 | US6858602 Compounds for the treatment of metabolic disorders |
| 02/22/2005 | US6858597 Halogenated sulphamate-, phosphonate-, thiophosphonate-, sulphonate- and sulphonamide- compounds as inhibitors of steroid sulphatase |
| 02/22/2005 | US6858592 Prevent absorption of fats |
| 02/22/2005 | US6858578 Chimeric proteins for use in transport of a selected substance into cells |
| 02/22/2005 | US6858416 Human desaturase gene and uses thereof |
| 02/22/2005 | US6858236 Nutriceutical and drug compositions containing a plant extract or concentrate from the genus Lycopersicon (tomato); bone disorders, e.g., Paget's disease, tumor-induced bone disease or particularly osteoporosis; metabolic disorders |
| 02/22/2005 | US6858228 Compression of drug and adjuvant |
| 02/22/2005 | US6858206 Methods for treating diseases caused by deficiencies of recombinant alpha-L-iduronidase |
| 02/22/2005 | US6858203 Treating of hyperphosphatemia by ingesting a ion exchanging resin comprising an allyl addition polymer having an amine salt or quaternary amine functional group; side effect reduction |
| 02/22/2005 | CA2236256C A pharmaceutical composition for the treatment of autoimmune diseases |
| 02/22/2005 | CA2220434C The use of epidermal growth factor as a gastrointestinal therapeutic agent |
| 02/22/2005 | CA2106423C Stabilized pharmaceutical compositions containing derivatives of vitamins d2 and d3 |
| 02/17/2005 | WO2005014634A1 A gene and uses therefor |
| 02/17/2005 | WO2005014592A1 2-amino-5-benzoylthiazole npy antagonists |
| 02/17/2005 | WO2005014576A1 Isoquinolinone derivative, process for producing the same and use thereof |
| 02/17/2005 | WO2005014541A1 Novel antihypercholesterolemic compound |
| 02/17/2005 | WO2005014521A1 Butenoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and use for the treatment of dyslipidaemia, atherosclerosis and diabetes |
| 02/17/2005 | WO2005014045A1 Active substance combination comprising a compound with npy receptor affinity and a compound with 5-ht6 receptor affinity |
| 02/17/2005 | WO2005014029A2 Use of dg008, dg065, dg210 or dg 239 secreted protein products for preventing and treating pancreatic diseases, obesity or metabolic syndrome |
| 02/17/2005 | WO2005014022A1 Use of pleitrophin for preventing and treating pancreatic diseases and/or obesity and/or metabolic syndrome |
| 02/17/2005 | WO2005014020A1 Compositions incorporating high-caffeine green tea extract and related methods for promoting healthy body weight |
| 02/17/2005 | WO2005013990A1 2-`4-(hydroxymethyl-phenylamino) -piperidine-1-yl!-n- (9h-carbazol-3-yl) - acetamine derivatives and related compounds as neuropeptide y5 (npy5) ligands for the treatment of obesity |
| 02/17/2005 | WO2005013988A1 2-`4(phenylamino)-piperidin-1-yl!-n-phenyl-acetamine derivatives and related compounds as neuropeptide y5 (npy5) ligands for the treatement of obesity |
| 02/17/2005 | WO2005013981A1 Heterocyclic amide derivatives which possess glycogen phosphorylase inhibitory activity |
| 02/17/2005 | WO2005013979A1 Indol-7 sulfonamide derivatives, their preparation and their use 5-ht-6 as modulators |
| 02/17/2005 | WO2005013978A1 Indol-4 sulfonamide derivatives, their preparation and their use 5-ht-6 as modulators |
| 02/17/2005 | WO2005013977A1 Indol-5-yl sulfonamide derivatives, their preparation and their use 5-ht-6 as modulators |
| 02/17/2005 | WO2005013976A1 Indol-6 sulfonamide derivatives, their preparation and their use 5-ht-6 as modulators |
| 02/17/2005 | WO2005013975A1 Indolamide derivatives which possess glycogen phosphorylase inhibitory activity |
| 02/17/2005 | WO2005013974A1 1-sulfonylindole derivatives, their preparation and their use as 5-ht6 ligands |
| 02/17/2005 | WO2005013966A1 Macrophage activation inhibitor |
| 02/17/2005 | WO2005013964A1 Pharmaceutical preparation containing nateglinide |
| 02/17/2005 | WO2005013957A2 Solid dispersible and/or orodispersible non-filmy containing at least one type of active substance pharmaceutical composition and method for the preparation thereof |
| 02/17/2005 | WO2005013956A1 Novel composition comprising rosiglitazone and another antidiabetic agent |
| 02/17/2005 | WO2005013938A1 Process for producing drug ultramicroparticle and apparatus therefor |
| 02/17/2005 | WO2004090118A8 Lactobacillus plantarum strain st-iii and its use in adjusting blood fat |
| 02/17/2005 | WO2004087173B1 Formulations for mediating inflammation and for reducing blood cholesterol |
| 02/17/2005 | WO2004081046A3 Human monoclonal antibodies against apociii and their use in the therapy of atherosclerosis |
| 02/17/2005 | WO2004070050A3 Cyclic urea derivatives, preparation method thereof and pharmaceutical use of same as kinase inhibitors |
| 02/17/2005 | WO2004067489A8 Hydroxyl compounds and compositions for cholesterol management and related uses |
| 02/17/2005 | WO2003099192A8 Bis-aromatic alkanols |
| 02/17/2005 | WO2003080568A3 Probucol derivatives |
| 02/17/2005 | WO2003050258A3 Endogenous retrovirus polypeptides linked to oncogenic transformation |
| 02/17/2005 | WO2003025131A3 Protein modification and maintenance molecules |
| 02/17/2005 | WO2002074913A3 Nucleic acid-associated proteins |
| 02/17/2005 | US20050038415 Method and apparatus for the treatment of obesity |
| 02/17/2005 | US20050038230 For decreasing food intake; eating disorders; sexual disorders |
| 02/17/2005 | US20050038126 Administering mammal a bicyclo [3.2.1]octan in a double ring system having kaurene structure such as steviol, isosteviol and stevioside; synergistic mixture with soy protein, and/or fiber and/or isoflavone |
| 02/17/2005 | US20050038095 Azolylbenzamides and analogues and their use for treating osteoporosis |
| 02/17/2005 | US20050038089 Thiazole derivatives |
| 02/17/2005 | US20050038084 Phenylalanine enamide derivatives |
| 02/17/2005 | US20050038061 6-Aminomorphinane derivatives, method for production and use thereof |
| 02/17/2005 | US20050038060 Spiropoperidine compounds as ligands for orl-1 receptor |
| 02/17/2005 | US20050038045 A2B adenosine receptor antagonists |
| 02/17/2005 | US20050038027 Melanocortin-4 receptor agonists; obesity, type II diabetes; such as N-(2-(2-(2,4-dichlorophenyl)ethyl)-1-oxo-2,3-dihydro-1H-isoindol-5-yl) -3-methyl-N'-(2,6,6-trimethylbicyclo(3.1.1)hept-3yl)piperazine-1-carboximidamide |